Intravenous Use of Cephradine and Cefazolin Against Serious Infections
The relative efficacy and safety of cephradine and cefazolin were compared in 180 patients with a variety of serious infections caused by susceptible organisms. The patients were randomly assigned to one of two groups of 90 patients each. Most patients received 2 to 4 g per day, administered by intr...
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1979
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352609/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/426499/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.1.119 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|